MAY 30, 2017 10:08 AM PDT

Two Genetic Variants Discovered in Association with Bicuspid Aortic Valve Disease

WRITTEN BY: Kara Marker

What happens during development to create the most common congenital heart defect, a bicuspid aortic valve (BAV)? The identification of two genetic variants linked to BAV is the newest step forward, made by researchers during a new study from the University of Michigan, published in the journal Nature Communications.

Researchers report a key protein is affected during heart valve formation, in the first genome-wide study of bicuspid aortic valve. Credit: Michigan Medicine

The Michigan Medicine study is the first successful genome-wide association study (GWAS) of patients with BAV. Thanks to the results from the GWAS, two new genetic variants were linked to this defect, both influencing a key cardiac transcription factor called GATA4, which is connected to cardiovascular development in the womb. GATA4 mutations have been studied in the best in relation to other heart defects.

"One of the regions we identify actually changes the protein coded by the gene, and the other likely changes expression levels of GATA4 during valve formation," explained senior author Cristen Willer, PhD. While Willer and her team are still figuring out the details, the two genetic variants somehow cause disruption during the “endothelial-mesenchymal transition,” an important part of aortic valve development.

The research team completed their GWAS with the help of 466 BAV patients and 4660 controls from the University of Michigan, as well as 1326 BAV patients and 8,103 controls from other institutions for a follow-up study to confirm their results. After identifying the two GATA4-linked genetic variants, researchers altered white blood cells to reassume a stem cell state, changing their genetic code in order to study the effects of the genetic variants on aortic valve development.

The University of Michigan researchers plan on continuing their study of the two newly-identified genetic variants and their involvement during BAV development.

About bicuspid aortic valve defects

People with BAV - also referred to as having bicuspid aortic valve disease - develop aortic valves with two leaflets, or holes for blood to flow through, instead of the typical three. The aortic valve is a particularly bad place in the heart for a defect; the aorta is the primary artery connecting the heart to the rest of the body and providing oxygen- and nutrient-rich blood to the body tissues. Therefore, people with BAV have limited blood-pumping function and often suffer complications associated with reduced blood flow to the body tissues: aortic stenosis (narrowed valve), aortic insufficiency or regurgitation (leaking valve), valve infection, aortic aneurysm.

 

Sources: Cleveland Clinic, University of Michigan

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 24, 2019
Genetics & Genomics
JUN 24, 2019
Genetic Predictors of a Failing Heart
Scientists have discovered a gene, PPP1R3A, that may be the ultimate protection against heart failure.  Evidence shows that once this gene turns on, i...
JUL 24, 2019
Cardiology
JUL 24, 2019
Eel Inspired Battery May Someday Power Pacemakers
The worlds first synthetic battery called a “voltaic stack” was developed by Alessandro Volta, an Italian scientist in 1799. The incredible bod...
AUG 01, 2019
Cardiology
AUG 01, 2019
Avoiding Sugar In Unexpected Places
Most people are under the false impression that what they eat is healthy. There is such a disconnect between the processed, prepackaged foods we eat today ...
SEP 09, 2019
Cardiology
SEP 09, 2019
Exercise Produces Greater Benefits In Those With Cardiovascular Disease
The fact that exercise benefits the heart and can help a person live a longer healthier life is well established. Exercising regularly can improve quality...
OCT 04, 2019
Cardiology
OCT 04, 2019
Heart Attacks Without The Risk
Following a heart attack, as the heart heals, scar tissue forms. This issue is less flexible than healthy heart tissue and may encumber the heart's abi...
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
FDA Approves Non-Statin Drug to Lower Cholesterol
The US Food and Drug Administration (FDA) has approved a new drug that lowers cholesterol levels.The drug, known as Nexletol, works differently from existi...
Loading Comments...